Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Stock-Based Compensation Expense) (Details)

v3.23.1
Stockholders' Equity (Stock-Based Compensation Expense) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 22,987 $ 19,486
Avenue Therapeutics, Inc [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 649 442
Checkpoint [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 2,924 3,137
Mustang    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 2,283 3,308
Journey    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 4,425 2,466
Other Partners [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 54 84
Employee Awards [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 9,934 8,603
Executive Awards [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 2,718 $ 1,446